PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.96%
Negative net income growth while Medical - Pharmaceuticals median is 3.68%. Seth Klarman would suspect a firm-specific problem if peers maintain profit growth.
5.15%
D&A growth under 50% of Medical - Pharmaceuticals median of 1.12%, or significantly exceeding it. Jim Chanos would suspect overcapacity or misallocated capex if new assets do not pay off quickly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.96%
Growth of 21.96% while Medical - Pharmaceuticals median is zero at 0.00%. Walter Schloss would question expansions or one-off revaluations explaining the difference.
5.15%
Operating cash flow growth at 75-90% of Medical - Pharmaceuticals median of 5.87%. John Neff would push for overhead or margin tweaks to match peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.